Lineage Cell Therapeutics Inc (LCTX)

[DeepDive]

Hi P, and welcome to the board, pretty deserted place, for the time being.

The visionary and leading scientist behind Ocata, Geron and almost all IP concerning Stem Cell Regenerative Medicine is Dr. Michael D. West.

https://en.m.wikipedia.org/wiki/Michael_D._West

Dr West was the CEO at Ocata, and developed or guided the main IP concerning embryonic stem cells (@Geron) and pluripotent stem cells at Btx.

Geron abandoned the mission of Regenerative Medicine and Dr west managed to get the whole IP for peanuts and it is now controlled and developed by Asterias a publicly listed not consolidated subsidiary. Check out their incredible Clinical trials AST-OPC1, Geron stared and abandoned. Amazing results.

At Biotime, Dr Michael continues innovating and expanding the range of Stem Cell medicine while medium to short term catalysts (Renevia for Cosmetic 7bill$ market) are one the horizon. You may want to look at the Biotime Site - there is an abundance of materials there, and sign up for email updates while you are there.

There is OncoCyte, listed subsidiary with its cancer blood test, at the final steps pre marketing. Check out that site for updates.

Investing wise, most Stem Cell companies are just disastrous businesses, with insane dilution and almost zero insider holdings.

@ Biotime, the lessons of past mistakes was learned. With minimal dilution massive progress is made and soon revenues will start flowing. The Board is composed of very large investors so the interests are aligned.

I believe Biotime' subsidiary Israeli CellCure - developing and clinically testing its RPE Stem Cell AMD therapeutic is superior to Ocata, you will find information on BTX's site.

Investing in BTX is buying a mutual fund of stem cell with INTEL INSIDE like IP. At the end, I believe, any therapeutic outside of Adult Stem Cell is going to be using this IP.

This is very early yet. One day, and not in the far future, there will be a mad rush to invest in Stem Cell businesses, probably after the FDA will start authorizing the first therapeutics. As I see it, the Top Dog is BTX.

I hope this helps.

Good luck!

Adi